- Home
- ICFI vs SRPT Comparison
ICFI vs SRPT Comparison
Compare ICFI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICFI
- SRPT
- Stock Information
- Founded
- ICFI 1969
- SRPT 1980
- Country
- ICFI United States
- SRPT United States
- Employees
- ICFI N/A
- SRPT N/A
- Industry
- ICFI Professional Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- ICFI Consumer Discretionary
- SRPT Health Care
- Exchange
- ICFI Nasdaq
- SRPT Nasdaq
- Market Cap
- ICFI 1.6B
- SRPT 1.7B
- IPO Year
- ICFI 2006
- SRPT 1997
- Fundamental
- Price
- ICFI $82.78
- SRPT $16.75
- Analyst Decision
- ICFI Buy
- SRPT Hold
- Analyst Count
- ICFI 4
- SRPT 29
- Target Price
- ICFI $115.50
- SRPT $46.46
- AVG Volume (30 Days)
- ICFI 141.1K
- SRPT 19.6M
- Earning Date
- ICFI 07-31-2025
- SRPT 08-11-2025
- Dividend Yield
- ICFI 0.68%
- SRPT N/A
- EPS Growth
- ICFI 18.33
- SRPT N/A
- EPS
- ICFI 5.82
- SRPT N/A
- Revenue
- ICFI $2,012,969,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- ICFI N/A
- SRPT $3.52
- Revenue Next Year
- ICFI $1.54
- SRPT N/A
- P/E Ratio
- ICFI $14.14
- SRPT N/A
- Revenue Growth
- ICFI 1.95
- SRPT 59.15
- 52 Week Low
- ICFI $75.91
- SRPT $10.42
- 52 Week High
- ICFI $179.67
- SRPT $146.38
- Technical
- Relative Strength Index (RSI)
- ICFI 40.10
- SRPT 44.29
- Support Level
- ICFI $82.96
- SRPT $10.42
- Resistance Level
- ICFI $87.30
- SRPT $14.54
- Average True Range (ATR)
- ICFI 2.23
- SRPT 2.15
- MACD
- ICFI -0.32
- SRPT 0.66
- Stochastic Oscillator
- ICFI 9.96
- SRPT 50.88
About ICFI ICF International Inc.
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.